log in
Print | Back

Haynes and Boone

Rick A. Werner

Rick A. Werner

Partner

Expertise

  • Canada
  • Capital Markets and Securities
  • Corporate
  • Corporate Governance

WSG Practice Industries

Activity

Haynes and Boone
New York, U.S.A.

WSG Leadership

ABA Group
Member
Profile
Rick A. Werner serves as the co-chair of the firm's Capital Markets and Securities Practice Group. Rick represents issuers, investment banks and investors in a wide range of corporate transactions that includes securities offerings, venture capital financings and other forms of private equity investment, mergers and acquisitions, joint ventures, recapitalizations and spin-outs. Rick also advises clients on general corporate, securities compliance and reporting matters.

Rick's experience with public and private securities offerings includes initial and secondary offerings of equity and convertible securities, Rule 144A offerings, rights offerings and shelf registrations. He represents buyers and sellers in mergers, tender offers and asset and stock transactions. Rick also works on alternative financing transactions such as reverse-mergers, registered direct offerings and private investments in public equity (PIPEs). He has substantial experience with investment funds, and regularly advises hedge funds, venture capital funds, industry sector funds and arbitrage funds on matters ranging from fund formation, organizational structuring, and regulatory compliance to individual transaction representation, restructurings and asset management.

Rick is also a member of the board of directors of Haynes and Boone.

Bar Admissions

California
New York

Education

J.D., University of California, Los Angeles (UCLA) School of Law, 2000
B.A., Dartmouth College, 1997
Areas of Practice

Canada | Capital Markets and Securities | Corporate | Corporate Governance | Corporate Strategic M&A | Healthcare and Life Sciences | Investment Management | Life Sciences | Mergers and Acquisitions | Pharmaceuticals | Public Company Transactions | Regulatory Compliance | Venture Capital and Emerging Company

Professional Career

Significant Accomplishments

Represented Pioneer Power Solutions, Inc. in the sale of its liquid filled and dry type transformer businesses to Mill Point Capital for $65.5 million.
Represented Pulmatrix, Inc. in a reverse merger, concurrent Nasdaq listing and $27 million financing.
Represented Alliqua BioMedical, Inc. in the sale of its advanced biologic wound care business and therapeutic ultrasound platform products to Celularity, Inc. for $29.0 million.
Represented VBI Vaccines Inc. in multiple financings for gross proceeds in excess of $150 million.
Represented Lapolla Industries, Inc. in its sale to Icynene U.S. Holding Corp.in a transaction valued at $160 million.
Represented PhaseRx, Inc. in its initial public offering and Nasdaq listing.
Represented Kitov Pharmaceuticals Ltd. in its $13 million initial public offering and Nasdaq listing, as well as a $12 million follow-on public offering.
Represented SuperCom Ltd. In a $29 million follow-on public offering.
Represented RedHill Biopharma Ltd in multiple financings for gross proceeds of approximately $130 million.
Represented Alliqua BioMedical, Inc. in its acquisition of Celleration, Inc. for $30.4 million, and also in multiple financings for gross proceeds of approximately $60 million
Represented NanoVibronix Inc. in a $6 million underwritten offering and concurrent Nasdaq listing
Represented InspireMD, Inc. in multiple financings for gross proceeds in excess of $100 million

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021